ResearcherSun Yat-sen UniversityNo recent work listed

Zhi Wang

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5276-1413; OpenAlex author ID A5100376398. Sources: OpenAlex.

Their work

Papers: 1 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2019: 1 paper

Papers 1

HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1. Last author DOI 10.1016/j.ebiom.2019.05.013 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Yanan Lu · 1 shared paper, 2019 · strength 0.09
- Paper HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1. DOI 10.1016/j.ebiom.2019.05.013 ↗
Zhaofan Luo · 1 shared paper, 2019 · strength 0.09
- Paper HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1. DOI 10.1016/j.ebiom.2019.05.013 ↗
Huimou Chen · 1 shared paper, 2019 · strength 0.09
- Paper HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1. DOI 10.1016/j.ebiom.2019.05.013 ↗
Dongni Xu · 1 shared paper, 2019 · strength 0.09
- Paper HNF1A inhibition induces the resistance of pancreatic cancer cells to gemcitabine by targeting ABCB1. DOI 10.1016/j.ebiom.2019.05.013 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.